Infinium Global Research Pharmaceutical Contract Manufacturing Market | 页面 2

A latest report has been added to the wide database of Pharmaceutical Contract Manufacturing Market by Infinium Global Research.
This report studies the Pharmaceutical Contract Manufacturing Market by type of contract manufacturing (final dosage form, API/bulk
drug manufacturing) market status and outlook of global and major regions, from manufacturers, and end industries. The objective of
the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years.
Pharmaceutical Contract Manufacturing Market provides opportunities in micro markets for stakeholders to invest along with the
detailed analysis of competitive landscape, latest trends, and product offerings of the major companies in the Pharmaceutical Contract
Manufacturing Market. According to report the global pharmaceutical contract manufacturing market is projected to grow at a CAGR
of 8.4% over the forecast period of 2018-2024.
Segment Covered
The report on global pharmaceutical contract manufacturing market covers type of contract manufacturing segments. On the basis of
type of contract manufacturing the global pharmaceutical contract manufacturing market is categorized into final dosage form (FDF)
and API/bulk drug manufacturing.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this
section the key trends and market size for each geography is provided over the period of 2016-2024. The countries covered in the
North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and
among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the
growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the
market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a
CAGR of x.x% over the period of 2018-2024.
Companies Profiled:
The report provides profiles of the companies in the global pharmaceutical contract manufacturing market such as, Eli Lilly, Biogen,
Abbott, Dr. Reddy's Laboratories, Aenova, Baxter, Amgen, Hospira, Momenta Pharmaceuticals and Mitsubishi Tanabe Pharma.